TGF-β Negatively Regulates Mitf-E Expression and Canine Osteoclastogenesis.

Area of Science:

• Veterinary Science
• Cell Biology
• Biochemistry

Background:

• Osteoporosis prevalence is increasing in aging dogs due to an imbalance between osteoclast and osteoblast activity.
• Limited research exists on the specific mechanisms of canine osteoclastogenesis.
• Understanding canine osteoclast formation is crucial for addressing bone diseases in dogs.

Purpose of the Study:

• To establish reliable culture conditions for inducing osteoclasts from canine bone marrow cells.
• To identify key factors influencing canine osteoclastogenesis.
• To compare canine osteoclastogenesis with murine models, particularly the role of TGF-β.

Main Methods:

• Canine bone marrow mononuclear cells were cultured with macrophage colony-stimulating factor (M-CSF).
• Subsequent culture involved M-CSF and soluble receptor activator of NF-κB ligand (RANKL).
• Gene expression of microphthalmia-associated transcription factor (Mitf-E) and the effect of TGF-β were analyzed.

Main Results:

• Efficient osteoclast formation (tartrate-resistant acid phosphatase-positive multinucleated cells) was achieved using M-CSF and RANKL.
• Mitf-E expression was induced during canine osteoclastogenesis, similar to murine models.
• Transforming growth factor-β (TGF-β) inhibited, rather than enhanced, RANKL-induced osteoclastogenesis and Mitf-E expression in canine cells, indicating a species-specific response.

Conclusions:

• Established culture conditions effectively induce osteoclasts from canine bone marrow cells using M-CSF and RANKL.
• Canine osteoclastogenesis involves Mitf-E induction, consistent with murine models.
• The inhibitory role of TGF-β in canine osteoclastogenesis highlights species-specific differences and the need for canine-specific research.